1. Home
  2. OHI vs ARWR Comparison

OHI vs ARWR Comparison

Compare OHI & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Omega Healthcare Investors Inc.

OHI

Omega Healthcare Investors Inc.

SELL

Current Price

$45.66

Market Cap

14.0B

Sector

Real Estate

ML Signal

SELL

Logo Arrowhead Pharmaceuticals Inc.

ARWR

Arrowhead Pharmaceuticals Inc.

SELL

Current Price

$56.22

Market Cap

12.4B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
OHI
ARWR
Founded
N/A
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.0B
12.4B
IPO Year
2001
2009

Fundamental Metrics

Financial Performance
Metric
OHI
ARWR
Price
$45.66
$56.22
Analyst Decision
Buy
Strong Buy
Analyst Count
20
15
Target Price
$51.44
★ $107.36
AVG Volume (30 Days)
1.9M
★ 2.0M
Earning Date
11-03-2026
11-24-2026
Dividend Yield
★ 5.97%
N/A
EPS Growth
25.16
★ 99.80
EPS
★ 1.66
N/A
Revenue
★ $1,190,099,000.00
$16,142,321.00
Revenue This Year
N/A
N/A
Revenue Next Year
$6.48
N/A
P/E Ratio
$27.42
★ N/A
Revenue Growth
★ 13.19
N/A
52 Week Low
$39.26
$36.73
52 Week High
$52.39
$95.49

Technical Indicators

Market Signals
Indicator
OHI
ARWR
Relative Strength Index (RSI) 49.81 24.20
Support Level $45.17 $54.02
Resistance Level $46.90 $66.37
Average True Range (ATR) 0.81 2.14
MACD 0.09 -0.02
Stochastic Oscillator 66.96 3.06

Price Performance

Historical Comparison
OHI
ARWR

About OHI Omega Healthcare Investors Inc.

Omega Healthcare Investors Inc is a real estate investment trust that invests in healthcare-related real estate properties located in the United States (U.S.), the United Kingdom (U.K.), and Canada. The company's objective is to provide attractive returns to investors while serving as the preferred capital partner to its third-party healthcare operating companies and affiliates, as well as other third-party healthcare operators, allowing them to focus on delivering a high level of care to their resident patients. Omega's investment portfolio mainly consists of skilled nursing facilities, assisted living facilities (ALFs), including care homes in the U.K., independent living facilities, rehabilitation and acute care facilities, and continuing care retirement communities.

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.

Share on Social Networks: